Predictive role of a pharmacogenetic profiling in patients with advanced colorectal cancer (ACRC) treated with first-line, 5-fluorouracil/oxaliplatin chemotherapy

Graziano, F.; Ruzzo, Am; Loupakis, F.; Canestrari, E.; Santini, D.; Catalano,; Ficarelli, R.; Mari, D.; Bisonni, R.; Masi, G.; Schiavon, G.; Safina,; Maltese, P.; Pizzagalli, F.; Giordani, P.; Lippe, P.; Alessandroni, P.; Giustini, L.; Falcone, A.; Tonini, G.; Silva, Rr; Mattioli, R.; Menichetti, Et; Testa, E.; Lai,; Magnani, M.

Links

[hdl.handle.net]

Tools

Export citation

Search in Google Scholar

Predictive role of a pharmacogenetic profiling in patients with advanced colorectal cancer (ACRC) treated with first-line, 5-fluorouracil/oxaliplatin chemotherapy

Proceedings article published in 2006 by F. Graziano, Am Ruzzo, F. Loupakis, E. Canestrari, D. Santini, Catalano, R. Ficarelli, D. Mari, R. Bisonni, G. Masi, G. Schiavon, Safina, P. Maltese, F. Pizzagalli, P. Giordani and other authors.

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Preprint: policy unknown

Upload

Postprint: policy unknown

Upload

Published version: policy unknown

Upload